Latest News and Press Releases

NORTHBROOK, Ill., June 20, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it notified the NASDAQ...

NORTHBROOK, Ill., May 16, 2016 (GLOBE NEWSWIRE) --  Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial results for the...

NORTHBROOK, Ill., March 03, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced publication of a study that...

Corporate Highlights and Guidance: Record fourth quarter and fiscal year revenues of $6.8 million and $21.1million, respectivelyRevenue guidance for 2016 set at $28 million to $30 millionNext...

NORTHBROOK, Ill., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will...

Preliminary Fourth Quarter Revenue of $6.8 MillionPreliminary Full Year Revenue of $21.0 Million Exceeding Guidance of $18-20 Million35 New Customer Placements For Q4 2015 NORTHBROOK, Ill., Jan. 06,...

NORTHBROOK, Ill., Dec. 23, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, confirms that the Verigene®...

NORTHBROOK, Ill., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the completion...

NORTHBROOK, Ill., Dec. 17, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the pricing of a...

NORTHBROOK, Ill., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results...